Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 12, 2021Open Access

Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa

View Full Paper
Ask AI
Bookmark
Share

Authors

SMShabir A. MadhiNational Center for Disease ControlVBVicky L. BaillieSouth African Medical Research CouncilCCClare CutlandUniversity of the Witwatersrand

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Madhi et al. (2021) studied this question.

synapsesocial.com/papers/6a9fa4e23579a0ffc99c9384https://doi.org/10.1101/2021.02.10.21251247
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1SARS–CoV-2–specific T cell responses and correlations with COVID-19 patient predisposition2020 · 221 citations
  2. 2Developing Covid-19 Vaccines at Pandemic Speed2020 · 1,660 citations
  3. 3Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data2021 · 649 citations
  4. 4The Development of COVID-19 Vaccines2020 · 61 citations
  5. 5Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma2021 · 151 citations